A legal settlement "safe harbor" protecting certain Amarin Corp. PLC communications about off-label use of Vascepa (icosapent ethyl) may create an opening for truthful and non-misleading promotion of unapproved uses to consumers.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?